From: Burden of respiratory tract infections at post mortem in Zambian children
 | Xpert MTB/RIF Assay | PowerChek™ MTB/NTM Assaya | |
---|---|---|---|
 | MTB detected | MTB detected | NTM detected |
Overall | 30Â % (36/121) | 16Â % (12/73) | 62Â % (45/73) |
Lung pathology | Â | Â | Â |
Bronchopneumonia | 30Â % (18b/60) | 9Â % (3/35) | 63Â % (22/35) |
Interstitial pneumonitis | 60Â % (8/20) | 17Â % (2/12) | 67Â % (8/12) |
Tuberculosis (All forms) (PTB and/or EPTB) | 30Â % (3/10) | 67Â % (6/9) | 22Â % (2/9) |
EPTB | 100Â % (1/1) | 100Â % (1/1) | 0Â % (0/1) |
PTB | 22Â % (2/9) | 63Â % (5/8) | 20Â % (2/8) |
Cytomegalovirus pneumonia | 13Â % (1/8) | 0Â % (0/4) | 75Â % (3/4) |
Pneumocystis Jirovecii pneumonia | 17Â % (1/5) | 0Â % (0/3) | 67Â % (2/3) |
Pulmonary oedema | 33Â % (2/6) | 20Â % (1/5) | 80Â % (4/5) |
Candidiasis | 0Â % (0/3) | 0Â % (0/2) | 50Â % (1/2) |
Acute respiratory distress | 0Â % (0/1) | 0Â % (0/1) | 100Â % (1/1) |
Normal lungs | 20Â % (2/10) | 0Â % (0/7) | 72Â % (5/7) |